Date: May 25, 2016
Emily Larose
elarose@casselsbrock.com
t: 416 860 5217
f: 416 642 7162
Toronto
Suite 2100, Scotia Plaza
40 King Street West
Toronto, ON
Canada
M5H 3C2
Emily Larose is a partner in the firm’s Litigation Group and a member of the firm's cross-disciplinary Life
Sciences team. She provides advice and representation to stakeholders in various regulated industries, with
specific expertise working with Health Canada-regulated clients. She has experience advising on all manner of
regulatory issues, risk management and policy matters and applies her regulatory expertise to product liability
and class action litigation.
Emily's experience includes:
Providing advice on Health Canada regulatory issues, including pharmaceutical, medical device, food and
natural health product marketing compliance, labelling, licensing, and mandatory problem and adverse
event reporting
Managing compliance and mandatory reporting of incidents for consumer products under the Canada
Consumer Product Safety Act
Advising on product liability issues, such as risk management measures, managing recalls, and defending
individual and class action litigation
Making and responding to federal and provincial access to information requests
Advising foreign companies entering the Canadian products market on licensing and other regulatory
requirements
Advising retail pharmacy clients on professional, regulatory and drug benefit matters
Preparing and revising policies and agreements to reflect privacy legislation and best practices
Emily developed an interest in health law issues through her experiences at the Consent and Capacity Board
and with the College of Nurses of Ontario. This interest has been further developed through an in-house
secondment with the legal department of a multinational pharmaceutical company.
Emily is on the Editorial Board of Class Action Journal. She has published and spoken on a variety of topics
including the reuse of single-use medical devices, consumer product regulation in Canada, national class
actions, natural health product marketing, spoliation, cross-border discovery and access to information
actions, natural health product marketing, spoliation, cross-border discovery and access to information
requests.
As a former member of the firm’s Risk Management Committee, Emily is well versed in developing practical
and proactive solutions to manage and prevent risk exposure through policy development, implementation of
best practices and maximizing the use of technologies.
Call to the bar
Ontario, 2002
Associations
Defence Research Institute
Ontario Bar Association (Executive member, Health Law Section)
Canadian Bar Association
The Advocates' Society
Toronto Lawyers Association
MEDEC (Regulatory Affairs Steering Committee member)
Canadian Health Food Association (Regulatory Affairs Advisory Committee Member)
Expertise
Class Actions
Life Sciences
Litigation
Product Liability